---
layout: post
title: "Request for Nominations for Voting Members for the Genetic Metabolic Diseases Advisory Committee; Amendment of Notice"
date: 2026-02-05 19:08:17 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-03302
original_published: 2024-02-16 00:00:00 +0000
significance: 8.00
---

# Request for Nominations for Voting Members for the Genetic Metabolic Diseases Advisory Committee; Amendment of Notice

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 16, 2024 00:00 UTC
**Document Number:** 2024-03302

## Summary

The Food and Drug Administration (FDA) is announcing an amendment to the notice of the request for nominations for voting members excluding consumer and industry representatives, to serve on the Genetic Metabolic Diseases Advisory Committee (the Committee) in the Center for Drug Evaluation and Research. This request for nominations was announced in the Federal Register of December 13, 2023. The amendment is being made to reflect a change in the DATES portion of the document. There are no other changes.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/02/16/2024-03302/request-for-nominations-for-voting-members-for-the-genetic-metabolic-diseases-advisory-committee)
- API: https://www.federalregister.gov/api/v1/documents/2024-03302

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
